Following up last week's 13D filing on Green Dot, Starboard Value and its affiliates have taken a 7.5% stake in medical solutions company MEDNAX, Inc.(NYSE: MD).
Starboard included the following language in the "Purpose of Transaction" section of the 13D filing:
"The Reporting Persons purchased the Shares based on the Reporting Persons’ belief that the Shares, when purchased, were undervalued and represented an attractive investment opportunity."
According to the 13D filing, Starboard's average purchase price thus far has been ~$25.25 per share. Sign up to get free 13D Filing alerts, new filter options available.
Information provided here or in email alerts does not constitute investment advice nor an offer to sell securities. The information provided is for research purposely only and we do not take any responsibility for any loss or damage including and without limitation to any loss which may arise directly or indirectly from use of or reliance on such information. The writer of this article does not at the time of writing have a position in MD, but may potentially purchase or dispose of shares pending further analysis and market conditions.